Involvement of the upper gastrointestinal tract in sarcoidosis is rare, and an optimal treatment regimen remains to be determined. Here, we report 3 cases of upper gastrointestinal sarcoidosis in Japanese patients aged 57-70 years with or without epigastric symptoms and describe the clinical features, laboratory data, and upper endoscopy and pathological findings. Upper gastrointestinal sarcoidosis was diagnosed based on the presence of noncaseating epithelioid cell granuloma in the lamina propria in the stomach or duodenum. In conclusion, the possibility of upper gastrointestinal sarcoidosis should be considered in patients with epigastric symptoms and a history of sarcoidosis, even in those with stable disease.
Introduction
Sarcoidosis, a systemic inflammatory granulomatous disease of unknown etiology, rarely involves the upper gastrointestinal tract; however, its incidence may actually be higher than previously considered, as asymptomatic cases of upper gastrointestinal sarcoidosis may have been overlooked. Upper gastrointestinal sarcoidosis most commonly involves the stomach; duodenal involvement is extremely rare. Here, we report three cases of upper gastrointestinal sarcoidosis.
Cases Reports

Case 1
A 59-year-old man with a past history of abdominal aortic aneurysm (AAA), hypertension, nephrosclerosis, gastric ulcer, and chronic tympanitis presented with a 6-month history of epigastric discomfort and weight loss of 6 kg. Vital signs were normal, and physical examination revealed neither epigastric tenderness nor lymphadenopathy. Chest examination was unremarkable, and abdominal bruit was auscultated on abdominal examination. Laboratory findings revealed elevation of levels of transaminases, biliary enzymes, lysozyme, and renal failure (Table 1) . Chest X-ray, computed tomography (CT) and other characteristics of sarcoidosis are summarized in Table 2 . Magnetic resonance cholangiopancreatography (MRCP) showed suspicious findings suggestive of common bile stone. Upper endoscopy showed only a scar on the gastric angle without granuloma.
Cholecystitis with a common bile duct stone and chronic renal failure due to renal artery stenosis were among the differential diagnoses considered. Given the persistent elevation of levels of transaminases and biliary enzymes (AST, 78 U/ L; ALT, 67 U/L; ALP, 543 U/L; γ-GTP, 106 U/L) on Day 4 and his epigastric discomfort, we conducted endoscopic retrograde cholangiopancreatography on Day 16, which revealed an elevated lesion in the duodenal subpapilla (Fig. 1A) and slight dilatation of the bile and main pancreatic ducts, although no obstruction was evident. A biopsy revealed noncaseating epithelioid cell granuloma in the lamina (Fig. 1B) . Hepatic sarcoidosis was considered to be the cause of the elevated levels of liver enzymes, prompting liver biopsy, which revealed noncaseating epithelioid cell granulomas (Fig. 1C) . From these findings, we were able to diagnose the patient with duodenal and hepatic sarcoidosis with noncaseating epithelioid cell granulomas. Prednisolone (PSL) at an initial dose of 30 mg/day improved the symptoms and laboratory values. PSL was gradually reduced to a minimum dosage of 13 mg for 7 months. However, despite the patient's sarcoidosis being stable, he died 11 months after diagnosis of sarcoidosis from multiple organ failure and disseminated intravascular coagulation due to an infected AAA.
Case 2
A 53-year-old woman with a history of sarcoidosis was referred to us for further consultation regarding abnormal findings from a barium meal performed at a medical checkup. Twenty-four years previously, she had been diagnosed with sarcoidosis with noncaseating epithelioid cell granulomas in the right anterior scalene lymph nodes, BHL, iritis, elevated serum levels of ACE, and a negative purified protein derivative (PPD) skin test. Findings on physical examination were unremarkable. Hematological and biochemical findings were normal (Table 1) , and chest X-ray, CT, and other characteristics of sarcoidosis are summarized in Table 2 . Upper endoscopy revealed 5 elevated lesions with erosions on the anterior wall of the gastric body ( Fig. 2A) , and histological examination of a biopsy specimen showed noncaseating epithelioid cell granuloma in the lamina propria (Fig. 2B ). Immunohistochemistry using a PAB antibody (monoclonal antibody against Propionibacterium acnes [P. acnes]) was positive in the granuloma showing a granular pattern (Fig. 2C) . A diagnosis of gastric sarcoidosis was made based on these findings. The patient was conservatively managed without symptoms for 5 years after the diagnosis of gastric sarcoidosis, and a follow-up upper endoscopy one year later showed no remarkable changes.
Case 3
A 69-year-old woman presented with a 2-month history of epigastralgia on a background of sarcoidosis diagnosed 10 years previously. The diagnosis of sarcoidosis had been made based on the presence of noncaseating epithelioid cell granulomas in the left supraclavicular and inguinal lymph nodes and BHL and serum ACE levels. Physical examination revealed normal findings, with no abdominal tenderness Table 2 . Upper endoscopy revealed multiple scars on the lesser curvature of the gastric body (Fig. 3A) , and histological examination of a biopsy demonstrated noncaseating epithelioid cell granuloma in the lamina propria (Fig. 3B) , leading to a diagnosis of gastric sarcoidosis. Treatment with proton pump inhibitors (PPIs) resulted in gradual improvement of the epigastralgia. Follow-up upper endoscopy revealed a scar on the greater curvature at 12 months (Fig. 3C ) and on the posterior wall of the upper gastric body at 18 months (Fig. 3D) , with noncaseating epithelioid cell granulomas also present in these scars. Follow-up upper endoscopy also revealed improvement of inflammation around the scars on the lesser curvature of the gastric body at 12 months (Fig. 3E ). Despite treatment with PPIs, slight epigastralgia continued for two and a half years.
Discussion
Here, we reported the rare upper gastrointestinal involvement of sarcoidosis in three patients. Upper gastrointestinal sarcoidosis should be considered as a potential diagnosis even among patients under long-term observation and with stable disease. Endoscopic findings revealed gastric involvement with multiple scars despite PPI therapy in Case 3. We noted positive results for pathological PAB antibody in the granuloma in Case 2. These findings may help to elucidate the mechanism and treatment of sarcoidosis.
Recent epidemiologic data published in 2008 indicated that the prevalence of gastrointestinal sarcoidosis at the time was 1.6% among Japanese patients with sarcoidosis (1). The prevalence of clinically recognizable gastrointestinal sarcoidosis has been estimated to range from 0.1% to 0.9% (2), with the stomach (particularly the gastric antrum) being the most common site of involvement. Duodenal involvement is particularly rare, with only a few cases of duodenal sarcoidosis documented in the literature (as indicated by a PubMed search using the terms 'duodenum AND sarcoidosis') (3) (4) (5) (6) . A great number of cases of gastric sarcoidosis are clinically silent and may therefore be overlooked during upper endoscopy in the absence of abnormal gastric mucosa (7). Cases 1 and 3 discussed here presented with epigastric symptoms, but Case 2 was asymptomatic and was detected incidentally. Symptoms of gastric sarcoidosis include epigastralgia (75%), nausea, vomiting, hematemesis, and melena (7), which are usually related to either peptic ulceration or narrowing of the gastric lumen due to granulomatous inflammation and associated fibrosis of the gastric wall (8) .
Upper endoscopy should be considered in patients with persisting epigastralgia and may reveal benign or malignantappearing ulcers, gastritis, thickened mucosa, and nodular mucosal irregularities (9) . Although histopathological abnormalities in gastrointestinal sarcoidosis can be observed in all layers from the mucosa to subserosa, diagnosis is difficult without evidence of involvement of other organs. Diagnosis of gastrointestinal sarcoidosis in all cases was made based on the presence of granulomas in the lamina propria as well as in other organs. In Case 3, multiple scars were present in the gastric mucosa, suggesting recurrent ulceration. To the best of our knowledge, only one case of gastric sarcoidosis with multiple ulcers on the gastric antrum has been reported in the literature (8) ; therefore, the present report is the first report of recurrent gastric ulcers with gastric sarcoidosis.
With respect to the pathogenesis of sarcoidosis, granuloma formation has been reported to be promoted by Th1 inflammatory cytokines, namely IL-2, IFN-γ and TNF-β (10, 11). In addition, P. acnes has been associated with granuloma formation (12) , with 92% positive staining using the PAB antibody reported in Japanese cases of sarcoidosis. In the present study, staining with PAB antibody was positive in the gastric lesion in Case 2, suggesting an association between P. acnes and granuloma formation.
Traditionally, asymptomatic cases of gastrointestinal sarcoidosis are monitored, while symptomatic cases are treated with oral glucocorticoids depending on symptom severity, with 66% improvement of symptoms documented in a recent report (13) . PPIs may be effective in treating gastric ulceration (13, 14) , and here were shown to improve epigastralgia in Case 3. Tetracycline, an antibacterial and immune system-modifying agent, has been reported to improve cutaneous sarcoidosis (15) , but its efficacy in treating gastrointestinal sarcoidosis has not been reported. Similarly, little information is available regarding the role of immunosuppressive agents, and few reports have been published regarding the surgical management of gastrointestinal sarcoidosis. The optimal method for treating gastrointestinal sarcoidosis therefore remains to be determined.
In conclusion, upper gastrointestinal sarcoidosis is often difficult to detect due to the relative lack of symptoms, and its diagnosis requires evidence of involvement of other organs. Upper gastrointestinal sarcoidosis should be considered in the differential diagnosis of patients with gastrointestinal symptoms and a history of sarcoidosis, even in those with stable disease. Accumulation of additional cases is needed to determine the optimal method for treating upper gastrointestinal sarcoidosis.
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